These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20521135)

  • 21. Comparison of tumor volumes derived from glucose metabolic rate maps and SUV maps in dynamic 18F-FDG PET.
    Visser EP; Philippens ME; Kienhorst L; Kaanders JH; Corstens FH; de Geus-Oei LF; Oyen WJ
    J Nucl Med; 2008 Jun; 49(6):892-8. PubMed ID: 18483085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FDG PET-CT in cervical cancer: relationship between primary tumor FDG uptake and metastatic potential.
    Yilmaz M; Adli M; Celen Z; Zincirkeser S; Dirier A
    Nucl Med Commun; 2010 Jun; 31(6):526-31. PubMed ID: 20215979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of prognosis using standardized uptake value of 2-[(18)F] fluoro-2-deoxy-d-glucose positron emission tomography for nasopharyngeal carcinomas.
    Lee SW; Nam SY; Im KC; Kim JS; Choi EK; Ahn SD; Park SH; Kim SY; Lee BJ; Kim JH
    Radiother Oncol; 2008 May; 87(2):211-6. PubMed ID: 18237806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of hyperglycemia on brain and liver
    Viglianti BL; Wong KK; Wimer SM; Parameswaran A; Nan B; Ky C; Townsend DM; Rubello D; Frey KA; Gross MD
    Biomed Pharmacother; 2017 Apr; 88():1038-1045. PubMed ID: 28192877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical usefulness of dual-time FDG PET-CT in assessment of esophageal squamous cell carcinoma.
    Shum WY; Hsieh TC; Yeh JJ; Chen JH; Su CC; Liang JA; Kao CH
    Eur J Radiol; 2012 May; 81(5):1024-8. PubMed ID: 21458941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serial 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) to monitor treatment of bone-dominant metastatic breast cancer predicts time to progression (TTP).
    Specht JM; Tam SL; Kurland BF; Gralow JR; Livingston RB; Linden HM; Ellis GK; Schubert EK; Dunnwald LK; Mankoff DA
    Breast Cancer Res Treat; 2007 Sep; 105(1):87-94. PubMed ID: 17268819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Revisiting the prognostic value of preoperative (18)F-fluoro-2-deoxyglucose ( (18)F-FDG) positron emission tomography (PET) in early-stage (I & II) non-small cell lung cancers (NSCLC).
    Agarwal M; Brahmanday G; Bajaj SK; Ravikrishnan KP; Wong CY
    Eur J Nucl Med Mol Imaging; 2010 Apr; 37(4):691-8. PubMed ID: 19915840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for staging of primary extranodal head and neck lymphomas.
    Schrepfer T; Haerle SK; Strobel K; Schaefer N; Hälg RA; Huber GF
    Laryngoscope; 2010 May; 120(5):937-44. PubMed ID: 20422687
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Singh I; Bikas A; Garcia CA; Desale S; Wartofsky L; Burman KD
    Endocr Pract; 2017 Feb; 23(2):182-189. PubMed ID: 27849386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-resolution(18)F-fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for pituitary adenoma detection in Cushing disease.
    Chittiboina P; Montgomery BK; Millo C; Herscovitch P; Lonser RR
    J Neurosurg; 2015 Apr; 122(4):791-7. PubMed ID: 25479121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A pilot study of changes in (18)F-FDG uptake, calcification and global metabolic activity of the aorta with aging.
    Bural GG; Torigian DA; Botvinick E; Houseni M; Basu S; Chen W; Alavi A
    Hell J Nucl Med; 2009; 12(2):123-8. PubMed ID: 19675864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FDG-PET in healthy and epileptic Lagotto Romagnolo dogs and changes in brain glucose uptake with age.
    Jokinen TS; Haaparanta-Solin M; Viitmaa R; Grönroos TJ; Johansson J; Bergamasco L; Snellman M; Metsähonkala L
    Vet Radiol Ultrasound; 2014; 55(3):331-41. PubMed ID: 24354474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.
    Chen W; Cloughesy T; Kamdar N; Satyamurthy N; Bergsneider M; Liau L; Mischel P; Czernin J; Phelps ME; Silverman DH
    J Nucl Med; 2005 Jun; 46(6):945-52. PubMed ID: 15937304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative analysis of response to treatment with erlotinib in advanced non-small cell lung cancer using 18F-FDG and 3'-deoxy-3'-18F-fluorothymidine PET.
    Kahraman D; Scheffler M; Zander T; Nogova L; Lammertsma AA; Boellaard R; Neumaier B; Ullrich RT; Holstein A; Dietlein M; Wolf J; Kobe C
    J Nucl Med; 2011 Dec; 52(12):1871-7. PubMed ID: 22065872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel positron emission tomography/computed tomography of diffuse parenchymal lung disease combining a labeled somatostatin receptor analogue and 2-deoxy-2[18F]fluoro-D-glucose.
    Win T; Screaton NJ; Porter J; Endozo R; Wild D; Kayani I; Dickson J; Shortman RI; Reubi JC; Ell PJ; Groves AM
    Mol Imaging; 2012 Apr; 11(2):91-8. PubMed ID: 22469237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 18F-FDG PET and combined 18F-FDG-contrast CT parameters as predictors of tumor control for hepatocellular carcinoma after stereotactic ablative radiotherapy.
    Huang WY; Kao CH; Huang WS; Chen CM; Chang LP; Lee MS; Chao HL; Chiu CH; Lo CH; Jen YM
    J Nucl Med; 2013 Oct; 54(10):1710-6. PubMed ID: 23970365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between tumor glucose metabolism and multiparametric functional MRI (IVIM and R2*) metrics in cervical carcinoma: Evidence from integrated
    Li-Ou Z; Hong-Zan S; Xiao-Xi B; Zhong-Wei C; Zai-Ming L; Jun X; Qi-Yong G
    J Magn Reson Imaging; 2019 Jun; 49(6):1704-1712. PubMed ID: 30390401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brain glucose metabolism in diffuse large B-cell lymphoma patients as assessed with FDG-PET: impact on outcome and chemotherapy effects.
    Adams HJ; de Klerk JM; Fijnheer R; Heggelman BG; Dubois SV; Nievelstein RA; Kwee TC
    Acta Radiol; 2016 Jun; 57(6):733-41. PubMed ID: 26297729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High 2-[18F]fluoro-2-deoxy-d-glucose (18FDG) uptake measured by positron emission tomography is associated with reduced overall survival in patients with oral squamous cell carcinoma.
    Hofele C; Freier K; Thiele OC; Haberkorn U; Buchmann I
    Oral Oncol; 2009 Nov; 45(11):963-7. PubMed ID: 19665923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thyroid incidentaloma identified by ¹⁸F-fluorodeoxyglucose positron emission tomography with CT (FDG-PET/CT): clinical and pathological relevance.
    Pagano L; Samà MT; Morani F; Prodam F; Rudoni M; Boldorini R; Valente G; Marzullo P; Baldelli R; Appetecchia M; Isidoro C; Aimaretti G
    Clin Endocrinol (Oxf); 2011 Oct; 75(4):528-34. PubMed ID: 21575027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.